AnaCardio
PrivateLast Round
Series A
Extension
Jan 9, 2025
Est. Valuation
$1.71M
Total Funding Raised
$34.24M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AnaCardio is a clinical-stage biopharmaceutical company that develops novel drugs to treat heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnaCardio Comparables
Compare AnaCardio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zensun (Shanghai) Sci & Tech Co., Ltd. | 78% | |
| Cardurion Pharmaceuticals | 77% | |
| Seismic Pharmaceutical Holdings | 75% |
AnaCardio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 9, 2025 | ||||
| Series A | Sep 8, 2022 | ||||
| VC Round | Feb 3, 2022 | ||||
| Seed | Jun 17, 2021 |
Key People
Founding team and executive leadership
AnaCardio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3B FUTURE Health Fund | Series A |
| Industrifonden | Series A Extension, VC Round, Series A |
| Novo Holdings | Series A Extension |
| Karolinska Development AB | Series A, VC Round, Seed |
| Pureos Bioventures | Series A Extension |
| Flerie AB | Series A Extension, Series A |
| Sound Bioventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 32% MoM.
- May 15, 2026
Monthly visitors increased 31% MoM.
AnaCardio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AnaCardio's valuation, stock price, and market status.
Is AnaCardio a public or private company?
AnaCardio is a private company.
What is the current stock price of AnaCardio?
AnaCardio is a private company with no public stock price. No recent secondary market data is available.
How much is AnaCardio worth (valuation)?
AnaCardio's valuation is estimated at $1.7M based on funding round data.
Can I buy AnaCardio stock?
AnaCardio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AnaCardio's last funding round?
AnaCardio's most recent funding round was Series A Extension on June 17, 2021.
Who are the main investors in AnaCardio?
Key investors in AnaCardio include Industrifonden, Novo Holdings, Karolinska Development AB, Pureos Bioventures, Sound Bioventures.
Will AnaCardio IPO soon?
No public IPO plans have been announced for AnaCardio.
How can I track AnaCardio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AnaCardio's secondary market activity and sign up for updates.